id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FTC-2022-0027-0001,FTC,FTC-2022-0027,"Hikma Pharmaceuticals PLC/Custopharm, Inc.; Analysis of Agreement Containing Consent Orders To Aid Public Comment",Notice,,2022-05-04T04:00:00Z,2022,5,2022-05-04T04:00:00Z,2022-06-04T03:59:59Z,2022-05-17T01:00:33Z,2022-09532,0,0,090000648504cc42